Home > Healthcare > Analytical Instruments > Molecular Analysis > Diagnostic Specialty Enzymes Market

Diagnostic Specialty Enzymes Market Share

Report ID: GMI9686
Published Date: May 2024
Report Format: PDF

Download Free Sample

Diagnostic Specialty Enzymes Market Share

The market is fragmented owing to the presence of large number of established and small-scale vendors globally. Established players in the market have substantial financial resources to invest in research and development, acquisition, and expansion of existing enzyme production capacities. This offers them competitive edge over their rivals. Small companies are majorly involved in the researching and developing new diagnostic specialty enzymes focusing on niche areas or specific type of diagnostic testing technologies, which has contributed to the overall diversity in the market.

Diagnostic Specialty Enzymes Market Companies

Prominent players operating in the market include:

Agilent Technologies, Inc.
Amano Enzymes Inc.
American Laboratories, Inc.
BBI Solutions
Biocatalysts Ltd. (BRAIN Biotech Group)
Bio-Rad Laboratories, Inc.
Codexis, Inc.
F. Hoffmann-La Roche Ltd.
Merck KGaA
New England Biolabs
Novozymes A/S
QIAGEN NV
SEKISUI Diagnostics
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Diagnostic specialty enzymes industry size was worth USD 1.1 billion in 2023 and is projected to expand at 8.1% CAGR from 2024 to 2032, owing to the increasing adoption of molecular diagnostic tests, increasing demand for timely diagnosis of chronic diseases, and rapid adoption of point of care testing technologies.

The polymerase and nucleases product segment in the diagnostic specialty enzymes industry recorded 34.5% market share in 2023 and is estimated to depict substantial growth between 2024 and 2032, due to the increasing adoption of molecular diagnostic testing across in-vitro diagnostic testing laboratories.

The molecular diagnostics application segment in the diagnostic specialty enzymes industry accounted for USD 389.6 million in 2023 and is projected grow at significant rate from 2024 to 2032, due to their growing approval by regulatory authorities such as U.S. FDA and European Union (EU).

North America diagnostic specialty enzymes industry recorded 40.6% market share in 2023 and is anticipated to grow at significant rate between 2024 and 2032, led by the increasing adoption of new and advanced diagnostic tests such as digital PCR, Homogenous EIA, and point of care glucose monitoring tests.